Log In
Print
BCIQ
Print
Print this Print this
 

AZD2115

  Manage Alerts
Collapse Summary General Information
Company AstraZeneca plc
DescriptionMuscarinic antagonist and beta 2 receptor agonist (MABA)
Molecular Target Muscarinic receptor ; Adrenergic receptor beta 2 (ADRB2)
Mechanism of ActionAdrenergic receptor beta 2 (ADRB2) agonist; Muscarinic receptor antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationChronic obstructive pulmonary disease (COPD)
Indication DetailsTreat chronic obstructive pulmonary disease (COPD)
Regulatory Designation

Partner

Pulmagen Therapeutics Ltd.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today